These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 25994870

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children.
    Manuyakorn W, Siripool K, Kamchaisatian W, Pakakasama S, Visudtibhan A, Vilaiyuk S, Rujirawat T, Benjaponpitak S.
    Pediatr Allergy Immunol; 2013 May; 24(3):299-303. PubMed ID: 23551241
    [Abstract] [Full Text] [Related]

  • 3. Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy.
    Chaudhary N, Kabra M, Gulati S, Gupta YK, Pandey RM, Bhatia BD.
    BMC Pediatr; 2016 May 14; 16():66. PubMed ID: 27179628
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance.
    Kousar S, Wafai ZA, Wani MA, Jan TR, Andrabi KI.
    Int J Clin Pharmacol Ther; 2015 Jul 14; 53(7):504-16. PubMed ID: 25943175
    [Abstract] [Full Text] [Related]

  • 8. CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
    Franco V, Perucca E.
    Expert Opin Drug Metab Toxicol; 2015 Jul 14; 11(8):1269-79. PubMed ID: 26037375
    [Abstract] [Full Text] [Related]

  • 9. HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians.
    Su SC, Chen CB, Chang WC, Wang CW, Fan WL, Lu LY, Nakamura R, Saito Y, Ueta M, Kinoshita S, Sukasem C, Yampayon K, Kijsanayotin P, Nakkam N, Saksit N, Tassaneeyakul W, Aihara M, Lin YJ, Chang CJ, Wu T, Hung SI, Chung WH.
    Clin Pharmacol Ther; 2019 Feb 14; 105(2):476-485. PubMed ID: 30270535
    [Abstract] [Full Text] [Related]

  • 10. Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations.
    Guacci A, Chetta M, Rizzo F, Marchese G, De Filippo MR, Giurato G, Nassa G, Ravo M, Tarallo R, Rocco T, Operto FF, Weisz A, Coppola G.
    Seizure; 2016 Jan 14; 34():26-8. PubMed ID: 26658169
    [No Abstract] [Full Text] [Related]

  • 11. Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients.
    Thakkar AN, Bendkhale SR, Taur SR, Gogtay NJ, Thatte UM.
    Neurol India; 2012 Jan 14; 60(6):577-80. PubMed ID: 23287317
    [Abstract] [Full Text] [Related]

  • 12. CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes and phenytoin adverse reactions correlation.
    Twardowschy CA, Werneck LC, Scola RH, De Paola L, Silvado CE.
    Arq Neuropsiquiatr; 2011 Apr 14; 69(2A):153-8. PubMed ID: 21537551
    [Abstract] [Full Text] [Related]

  • 13. Association of CYP2C9*3 with phenytoin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis.
    Wu X, Liu W, Zhou W.
    J Clin Pharm Ther; 2018 Jun 14; 43(3):408-413. PubMed ID: 29274302
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. HLA-B*51:01 and CYP2C9*3 Are Risk Factors for Phenytoin-Induced Eruption in the Japanese Population: Analysis of Data From the Biobank Japan Project.
    Hikino K, Ozeki T, Koido M, Terao C, Kamatani Y, Mizukawa Y, Shiohara T, Tohyama M, Azukizawa H, Aihara M, Nihara H, Morita E, Murakami Y, Kubo M, Mushiroda T.
    Clin Pharmacol Ther; 2020 May 14; 107(5):1170-1178. PubMed ID: 31646624
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
    Chang WC, Hung SI, Carleton BC, Chung WH.
    Expert Opin Drug Metab Toxicol; 2020 Aug 14; 16(8):723-734. PubMed ID: 32510242
    [Abstract] [Full Text] [Related]

  • 18. Phenytoin toxicity in two-month-old Thai infant with CYP2C9 gene polymorphism--A case report.
    Veeravigrom M, Jaroonvanichkul V, Netbaramee W, Phaisarn P, Uyathanarat T.
    Brain Dev; 2016 Jan 14; 38(1):136-8. PubMed ID: 25998968
    [Abstract] [Full Text] [Related]

  • 19. Influenza immunization does not predominantly alter levels of phenytoin, and cytochrome P-450 enzymes in epileptic patients receiving phenytoin monotherapy.
    Soontornpun A, Manoyana N, Apaijai N, Pinyopornpanish K, Pinyopornpanish K, Nadsasarn A, Tanprawate S, Chattipakorn N, Chattipakorn SC.
    Epilepsy Res; 2020 Nov 14; 167():106471. PubMed ID: 33007725
    [Abstract] [Full Text] [Related]

  • 20. The association between CYP2C9/2C19 polymorphisms and phenytoin maintenance doses in Asian epileptic patients: A systematic review and meta-analysis
.
    Liao K, Liu Y, Ai CZ, Yu X, Li W.
    Int J Clin Pharmacol Ther; 2018 Jul 14; 56(7):337-346. PubMed ID: 29628024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.